Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic

Pfizer Ventures led the Series B financing of Cartography Biosciences, whose lead program addresses a promising target for colorectal cancer. The startup’s drugs come from platform technologies that analyze data from healthy cells and cancer cells to identify cancer-specific targets. The post Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic…

Read More

Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem

Success requires orchestrating an end-to-end experience that connects manufacturing, logistics, clinical sites, payers, and patients seamlessly. The companies that treat this orchestration as a strategic competency, rather than just operational logistics, will be best positioned to scale. The post Scaling Radioligand Therapy: 3 Essential Strategies From Inside The Ecosystem appeared first on MedCity News.

Read More